Atopic dermatitis, systemic sclerosis, asteatotic eczema, others
Conditions
Interventions
Patients with skin diseases will be divided into two groups: Group A (skin care instruction at the beginning and 4 weeks after the start of the study) and Group B (skin care instruction 4 weeks after
Sponsors
Yoshizaki Ayumi
Sato Shinichi
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Patients who meet all of the following criteria 1)~5) 1) Patients with skin diseases 2) Patients who do not plan to change the drug used to treat the primary disease (no restriction on change in dosage). 3) Be male or female, 20 years of age or older. 4) The subject must be able to practice the skincare instructed at home by him/herself. 5) Patients who have been fully informed about their participation in this study, and who have given written consent of their own free will based on sufficient understanding.
Exclusion criteria
Exclusion criteria: 1) Persons who have experienced contact dermatitis or other skin conditions caused by the ingredients contained in this skincare product or similar ingredients in the past. 2) Patients who have skin rashes or other skin conditions inappropriate for the application of this skincare product to the area of application. 3) Patients who cannot be examined after 4 to 8 weeks (in principle). 4) Pregnant or nursing mothers 5) Patients with psychiatric disorders or psychiatric symptoms that interfere with daily life and make it difficult for them to participate in the study. 6) Other patients who are deemed inappropriate as research subjects by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Improved drug application to the face | — |
Secondary
| Measure | Time frame |
|---|---|
| Changes in the stratum corneum water content, epidermal water transpiration, cytokines Patient quality of life survey Amount of topical agents used Skin age | — |
Contacts
Public ContactOmatsu Jun
The University of Tokyo Hospital
Outcome results
None listed